SuperworthEnsign EPS ENSG
Diluted earnings per share by quarter and over the last twelve months, from 2010.
- Last 12 months, to Jun 30, 2026
- $6.38
- Latest quarter, Q2 FY26
- $1.68
- +17% on a year earlier
- Fiscal year 2025
- $5.84
- +14% on the year before
Ensign's earnings per share was $6.38 over the twelve months to Jun 30, 2026, up 16% on a year earlier.
In its latest quarter, Q2 FY26, it was $1.68, up 17% on the same quarter a year before.
Over the five fiscal years to FY2025 it grew 14% a year on average.
Earnings per share over time
Fiscal year by fiscal year
| Fiscal year | EPS | Change |
|---|---|---|
| FY2025 | $5.84 | +14% |
| FY2024 | $5.11 | +40% |
| FY2023 | $3.66 | −7% |
| FY2022 | $3.95 | +15% |
| FY2021 | $3.42 | +12% |
| FY2020 | $3.05 | +55% |
| FY2019 | $1.97 | +16% |
| FY2018 | $1.70 | +124% |
| FY2017 | $0.76 | −21% |
| FY2016 | $0.96 | −10% |
| FY2015 | $1.07 | +37% |
| FY2014 | $0.78 | +49% |
| FY2013 | $0.53 | −43% |
| FY2012 | $0.93 | −16% |
| FY2011 | $1.10 | n/a |
Each fiscal year is the twelve months to its fourth quarter.
Quarter by quarter
| Quarter | Ended | EPS | On a year earlier | Last 12 months |
|---|---|---|---|---|
| Q2 FY26 | $1.68 | +17% | $6.38 | |
| Q1 FY26 | $1.67 | +22% | $6.14 | |
| Q4 FY25 | $1.61 | +18% | $5.84 | |
| Q3 FY25 | $1.42 | +6% | $5.59 | |
| Q2 FY25 | $1.44 | +18% | $5.51 | |
| Q1 FY25 | $1.37 | +15% | $5.29 | |
| Q4 FY24 | $1.36 | +258% | $5.11 | |
| Q3 FY24 | $1.34 | +21% | $4.13 | |
| Q2 FY24 | $1.22 | +9% | $3.90 | |
| Q1 FY24 | $1.19 | +13% | $3.80 | |
| Q4 FY23 | $0.38 | −64% | $3.66 | |
| Q3 FY23 | $1.11 | +12% | $4.34 |
Against its peers
Companies in Medical - Care Facilities nearest Ensign's size, closest first, today.
| Company | EPS, 12 months | Growth |
|---|---|---|
| ENSGEnsign | $6.38 | +16% a year |
| UHSUniversal Health Services | $24.55 | +29% a year |
| DVADavita | $12.22 | +20% a year |
| BTSGBrightSpring Health Services | $1.65 | +432% a year |
| EHCEncompass Health | $6.14 | +20% a year |
| PACSPACS | $1.75 | +113% a year |
| CHEChemed | $19.92 | +2% a year |
| SHCSotera Health | $0.57 | +613% a year |
| CONConcentra Group Holdings Parent | $1.54 | +29% a year |
| LFSTLifeStance Health | $0.13 | |
| THCTenet Healthcare | $25.93 | +66% a year |
| Peer median | $3.94 |
Where Ensign ranks
What the EPS figure tells you
Net income divided by diluted shares. The denominator of PE.
One-off charges and gains swing it. The TTM view smooths a single odd quarter.
More on Ensign
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.